There are other factors, but researchers say certain genes make drinking a pleasant or unpleasant experience.
A gene that regulates how quickly the body metabolizes alcohol plays a significant role in risk for alcohol dependence, a new study says.
It’s not the only factor in alcoholism risk. Culture, environment, and other genes also play a part, experts say.
However, the findings could help develop new treatments for the disease.
“We are influenced by nature, nurture, and what I call neighborhood, or the community that surrounds you,” Dr. Michael Genovese, chief medical officer of addiction and mental health treatment provider Acadia Healthcare, told Healthline. “People can have a genetic susceptibility to alcohol dependence, which often coincides with susceptibility to other mental health conditions.”
“At the same time,” he added, “repeated exposure to alcohol consumption and abuse can impact drinking behaviors later in life. Continued genetic research is critical as it can eliminate guesswork and help with the identification, prevention, and individualized treatment of substance use disorder.”
They found that those who carried the ADH1B variant of the alcohol dehydrogenase (ADH) gene, which regulates how the body converts alcohol to a substance called acetaldehyde, were more likely to become alcohol dependent than those who lacked this variant of the gene.
ADH1B significantly reduces the clearance rate of alcohol from the liver.
But people with ADH1B*2, another variant of the ADH gene, rapidly process alcohol, quickly elevating levels of acetaldehyde, the alcohol metabolite that causes hangovers.
Gene variants ALDH1A1*2 and ALDH1A1*3, often found in African-Americans, also have been associated with a high risk of alcoholism, according to psychiatrist and addiction medicine expert Dr. Indra Cidambi, founder of the Center for Network Therapy.
On the other hand, previous studies have shown that people with the ADH1B*2 gene variant — including many individuals of Asian descent — are at reduced risk of alcohol dependence, probably because of the unpleasant effects of acetaldehyde associated with drinking.
The new study included genetic data from people of European and African ancestry. The same ADH1B gene was linked to alcoholism risk in both populations but in different variants.
“Genetic differences in these enzymes explains why certain ethnic groups have lower rates of alcohol-related problems,” Cidambi told Healthline.
Carriers of ADH1B experience fewer adverse side effects when drinking due to their slower alcohol metabolism, which could explain their elevated risk.
“The strong ‘Asian flushing’ response, which includes rapid heartbeat, nausea, and other unpleasant feelings, tends to decrease drinking,” Arpana Agrawal, PhD, a researcher at Washington University School of Medicine in St. Louis, told Healthline.
“The biggest contributor to that reaction is a variant in aldehyde dehydrogenase 2 (ALDH2) that greatly slows the removal of the aversive acetaldehyde. Many individuals in Asian populations have that variant, as well as one of the protective variants in ADH1B that speeds the processing of alcohol. These variants in alcohol metabolism have the strongest, best-documented impact on risk for alcoholism.”
Disulfiram (Antabuse), the first drug approved by the U.S. Food and Drug Administration (FDA) to treat alcohol dependence, works by disrupting the metabolism of acetaldehyde into harmless acetic acid.
This disruption causes a range of unpleasant side effects when alcohol is consumed.
Genes may also play a role in the effectiveness of the drug naltrexone, used to prevent relapse to drinking among people who misuse alcohol.
The drug has been shown to work in some, but not all, people with alcohol dependence, according to the National Institute of Alcohol Abuse and Alcoholism (NIAAA).
The new study also found that several other genes may contribute to risk of alcohol dependence.
“The risk conferred by the ADH1B gene is one of the strongest single-gene effects seen in people with a psychiatric illness, but overall, it explains only a small proportion of the risk,” said Agrawal.
“The gene we identified has a protective effect, but by no means is it the only thing affecting risk of alcohol dependence,” added Agrawal. “We know environmental factors also play a role. We also think the genetic susceptibility to alcohol dependence stems from the small, cumulative effects of a very large number of variants across the genome.”
NIAAA, which has funded the Collaborative Studies on Genetics of Alcoholism (COGA) since 1989 to identify the genes involved in alcohol use disorders, estimates that genes are responsible for about half of the risk for alcoholism.
Some of the genetic factors associated with the illness also appear to be linked to depression, schizophrenia, ADHD, and the use of cigarettes and marijuana, according to the new study.
Researchers also found that the genetic factors influencing whether people drank or abstained from alcohol use were different than those involved in alcohol dependence risk.
Agrawal and her colleagues examined data from 28 previous studies of alcoholism, and said that an even larger study is needed to broaden understanding of the role of genetics in alcoholism.
“As we analyze additional alcohol-dependent individuals, we should be able to find additional genomic regions affecting risk for alcohol dependence,” said Raymond Walters, PhD, the study’s first author and a post-doctoral research fellow at the Broad Institute of Massachusetts Institute of Technology and Harvard University.
About 1 in 8 people in the United States are considered alcohol dependent, according to NIAAA.
Genes play a role in risk of alcohol dependence.
Specific genetic variants affect alcohol metabolism, helping determine whether drinking is a pleasant or unpleasant experience.
Future research could establish a genetic profile for people at risk of alcoholism and help make treatments more effective.